Maravai LifeSciences Holdings, Inc. (MRVI)
| Previous close | 8.97 |
| Open | 8.95 |
| Bid | 8.88 x 400 |
| Ask | 8.98 x 100 |
| Day's range | 8.85 - 9.00 |
| 52-week range | 4.52 - 16.62 |
| Volume | |
| Avg. volume | 2,774,828 |
| Market cap | 2.251B |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.90 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 9.88 |
Business WireTriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
SAN DIEGO, April 30, 2024--TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
Business WireTriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
SAN DIEGO, April 18, 2024--TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
GlobeNewswireMaravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2024 financial and operating results after the market closes on Wednesday, May 8, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial (888) 596-4144 or (646) 968-2525 a
